These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22022383)

  • 1. Correlation versus causation? Pharmacovigilance of the analgesic flupirtine exemplifies the need for refined spontaneous ADR reporting.
    Anderson N; Borlak J
    PLoS One; 2011; 6(10):e25221. PubMed ID: 22022383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flupirtine-induced liver injury--seven cases from the Berlin Case-control Surveillance Study and review of the German spontaneous adverse drug reaction reporting database.
    Douros A; Bronder E; Andersohn F; Klimpel A; Thomae M; Orzechowski HD; Kreutz R; Garbe E
    Eur J Clin Pharmacol; 2014 Apr; 70(4):453-9. PubMed ID: 24366502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology of flupirtine-induced liver injury: a histological and clinical study of six cases.
    Puls F; Agne C; Klein F; Koch M; Rifai K; Manns MP; Borlak J; Kreipe HH
    Virchows Arch; 2011 Jun; 458(6):709-16. PubMed ID: 21590308
    [TBL] [Abstract][Full Text] [Related]  

  • 4.  Initially purported hepatotoxicity by Pelargonium sidoides: the dilemma of pharmacovigilance and proposals for improvement.
    Teschke R; Frenzel C; Wolff A; Herzog J; Glass X; Schulze J; Eickhoff A
    Ann Hepatol; 2012; 11(4):500-12. PubMed ID: 22700632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced liver injury in Switzerland: an analysis of drug-related hepatic disorders in the WHO pharmacovigilance database VigiBase from 2010 to 2020.
    Ortland I; Mirjalili M; Kullak-Ublick GA; Peymani P
    Swiss Med Wkly; 2021 May; 151():w20503. PubMed ID: 34000058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in reporting drug-associated liver injuries in Taiwan: a focus on amiodarone.
    Ye JH; Ho YF; On AW; Chen WW; Huang YM; Huang WI; Tang YW
    Int J Clin Pharm; 2018 Aug; 40(4):911-920. PubMed ID: 30051228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Landscape of Hepatobiliary Adverse Drug Reactions Related to Preparations Containing Psoraleae Fructus and Its Application in Pharmacovigilance.
    Ge FL; Niu M; Han ZX; Cao JL; Wang JB; Bai ZF; Song HB; Guo YM; Xiao XH
    Chin J Integr Med; 2021 Nov; 27(11):832-837. PubMed ID: 33963478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury.
    Das S; Behera SK; Xavier AS; Velupula S; Dkhar SA; Selvarajan S
    Clin Drug Investig; 2018 Mar; 38(3):211-218. PubMed ID: 29185238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abuse liability of flupirtine revisited: implications of spontaneous reports of adverse drug reactions.
    Gahr M; Freudenmann RW; Connemann BJ; Hiemke C; Schönfeldt-Lecuona C
    J Clin Pharmacol; 2013 Dec; 53(12):1328-33. PubMed ID: 24037995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug induced hepatotoxicity: data from the Serbian pharmacovigilance database.
    Petronijevic M; Ilic K; Suzuki A
    Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):416-23. PubMed ID: 21370308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacovigilance and herbal hepatotoxicity: critical aspects and solutions].
    Teschke R; Schulze J
    Dtsch Med Wochenschr; 2013 Feb; 138(6):281-4. PubMed ID: 23361353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.
    Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R
    Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence.
    Sharma PK; Misra AK; Gupta A; Singh S; Dhamija P; Pareek P
    Indian J Pharmacol; 2018; 50(5):273-278. PubMed ID: 30636831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylcysteine and prednisolone treatment improved serum biochemistries in suspected flupirtine cases of severe idiosyncratic liver injury.
    Borlak J; van Bömmel F; Berg T
    Liver Int; 2018 Feb; 38(2):365-376. PubMed ID: 28782153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of spontaneous reporting of suspected adverse drug reactions for non-analgesic over-the-counter drugs from 2008 to 2017.
    Bukic J; Rusic D; Mas P; Karabatic D; Bozic J; Seselja Perisin A; Leskur D; Krnic D; Tomic S; Modun D
    BMC Pharmacol Toxicol; 2019 Oct; 20(1):60. PubMed ID: 31627740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of risk minimization measures on compliance and prescribing practices of flupirtine in Germany.
    Kaplan S; Ehlken B; Hamann X
    Curr Med Res Opin; 2019 Jan; 35(1):33-40. PubMed ID: 29992843
    [No Abstract]   [Full Text] [Related]  

  • 19. A tailor-made approach for causality assessment for ADR reports on drugs and vaccines.
    Oosterhuis I; Zweers P; Rümke H; Muller-Hansma A; van Puijenbroek EP
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):544-550. PubMed ID: 30168222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric pharmacovigilance in an institute of national importance: Journey has just begun.
    Sharma PK; Misra AK; Gupta N; Khera D; Gupta A; Khera P
    Indian J Pharmacol; 2017; 49(5):390-395. PubMed ID: 29515280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.